Chemical Properties
| form | Liquid |
| color | Colorless to light yellow |
Gantenerumab Chemical Properties,Usage,Production
Uses
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease being developed by Hoffmann-La Roche pharmaceuticals.in vivo
Gantenerumab (20 mg/kg; intravenous injection; once a week; 5 months) has a protective effect in PS2APP transgenic mice and can reduce the number of Aβ amyloid plaques[1].
| Animal Model: | PS2APP transgenic mice by administering a single anti-CD4 injection[1] |
| Dosage: | 20 mg/kg |
| Administration: | Intravenous injection; once a week; 5 months |
| Result: | Reduced the number of Aβ amyloid plaques in PS2APP mice compared with vehicle controls. Specifically, in the hippocampus, neocortex, and thalamus, the plaque numbers were significantly reduced by 36%, 40%, and 70% respectively. Efficiently reduced the number of smaller plaques. Did not cause neurological or locomotor deficits. |
Gantenerumab Suppliers
Global(25)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| tp@aladdinsci.com | 54731 | 58 | |||
| +86-0086-13720134139 | orders@jknbiochem.com | 5214 | 58 | ||
| 15817493340 | 981810490@qq.com | 1577 | 58 | ||
| 027-65279366 18108604356 | products@biolabreagent.com | 9864 | 58 | ||
| 021-65675885 18964387627 | customer_service@efebio.com | 11963 | 58 | ||
| 0573-83568680 18057391398 | 3956524501@qq.com | 1441 | 58 | ||
| 027-87008169 17762441161 | info@atagenix.com | 9997 | 58 | ||
| 18916372613 | yanzihan@shyuanye.com | 87240 | 60 | ||
| 4008200310 15002144251 | marketing@tsbiochem.com | 24951 | 58 | ||
| 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | 7353 | 58 |